SEC Form 25-NSE filed by HH&L Acquisition Co.

2/23/24 10:50:57 AM ET

$HHLA

Medical Specialities

Health Care

Get the next $HHLA alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-40006

Issuer:	HH&L Acquisition Co.
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	Suite 3508, One Exchange Square
	Hong Kong
Telephone number:

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Class A Ordinary Shares; Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant; and Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2024-02-23	By	Victoria Paper		Manager, Market Watch and Proxy Compliance
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $HHLA alert in real time by email

SEC Form 25-NSE filed by HH&L Acquisition Co.

Chat with this insight

Recent Analyst Ratings for
$HHLA

$HHLA
Press Releases

Fastest customizable press release news feed in the world

DiaCarta Receives Accreditation by the College of American Pathologists (CAP)

DiaCarta Announces Five Abstracts Accepted for Presentation at AACR Annual Meeting 2023

DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit

$HHLA
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Highbridge Capital Management Llc sold $2,687,500 worth of Class A Ordinary Shares (250,000 units at $10.75) (SEC Form 4)

SEC Form 3: New insider Highbridge Capital Management Llc claimed ownership of 500,000 units of Class A Ordinary Shares

SEC Form 4 filed by HH&L Investment Co.

$HHLA
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by HH&L Acquisition Co.

SEC Form SC 13G filed by HH&L Acquisition Co.

SEC Form SC 13G/A filed by HH&L Acquisition Co. (Amendment)

$HHLA
SEC Filings